| 0 (0%) | 11-11 17:47 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1.05  |
1-year : | 1.28 |
| Resists | First : | 0.9 |
Second : | 1.1 |
| Pivot price | 0.71 |
|||
| Supports | First : | 0.58 |
Second : | 0.48 |
| MAs | MA(5) : | 0.63 |
MA(20) : | 0.73 |
| MA(100) : | 0.93 |
MA(250) : | 1.11 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 11.8 |
D(3) : | 13.5 |
| RSI | RSI(14): 34.6 |
|||
| 52-week | High : | 2.45 | Low : | 0.57 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ AKTX ] has closed above bottom band by 3.1%. Bollinger Bands are 3.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.65 - 0.66 | 0.66 - 0.66 |
| Low: | 0.57 - 0.58 | 0.58 - 0.58 |
| Close: | 0.58 - 0.59 | 0.59 - 0.6 |
Tue, 11 Nov 2025
What technical signals suggest for AKTX stock - 2025 Trade Ideas & High Conviction Investment Ideas - newser.com
Mon, 10 Nov 2025
Akari Therapeutics (AKTX) Reveals New Data on ADC Payload PH1 - GuruFocus
Mon, 10 Nov 2025
Akari (NASDAQ: AKTX) shows PH1 ADC + anti-PD1 74% CR vs 42% in HER2+ colon model - Stock Titan
Mon, 10 Nov 2025
Is AKTX stock supported by innovation pipeline - 2025 Volume Leaders & AI Powered Trade Plan Recommendations - newser.com
Mon, 10 Nov 2025
What to do if you’re stuck in AKTX - Short Setup & Capital Efficient Trade Techniques - newser.com
Sun, 09 Nov 2025
Is AKTX forming a reversal pattern - July 2025 Summary & Daily Technical Forecast Reports - newser.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 33 (M) |
| Shares Float | 11,220 (M) |
| Held by Insiders | 31.2 (%) |
| Held by Institutions | 1.5 (%) |
| Shares Short | 248 (K) |
| Shares Short P.Month | 85 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.79 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -28.6 % |
| Return on Equity (ttm) | -112.1 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.4 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -9 (M) |
| Levered Free Cash Flow | 3 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0.74 |
| Price to Sales | 0 |
| Price to Cash Flow | -2.14 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|